







He revolutionized the way we view MDMA-assisted psychotherapy. But what does the research actually show?
FDA Designates MDMA As 'Breakthrough Therapy' For Post-Traumatic Stress
The drug, often used recreationally in the form of ecstasy, has been found to offer a potentially significant advantage over extant treatments for the disorder.

Why more B.C. health-care workers are training to provide MDMA-assisted psychotherapy | CBC News
As more promising research emerges about MDMA — a recreational drug also known as ecstasy or molly — so too has interest grown in how health-care practitioners can be equipped to treat their patients using MDMA, says a B.C. non-profit.

A Balm for Psyches Scarred by War (Published 2022)
MDMA-assisted treatment for post-traumatic stress disorder “represents real hope for long-term healing,” health experts say.

The brain on MDMA can go somewhere CBT has never been able to reach | Rachel Yehuda: Full Interview
Metapsy | Meta-Analytic Psychotherapy Databases
Metapsy is a university-based research project. It provides access to meta-analytic databases of clinical trials on the effect of psychological interventions on mental disorders or mental health problems.
The Yale Manual for Psilocybin-Assisted Therapy of Depression (using Acceptance and Commitment Therapy as a Therapeutic Frame)
The Yale Manual for Psilocybin-Assisted Therapy of Depression provides researchers and therapists with methods, structure, and areas to consider regarding the use of psychedelic- assisted therapy in the treatment of Major Depressive Disorder (MDD). In particular, this manual illustrates a mode of utilizing Acceptance and Commitment Therapy (ACT) as a therapeutic framework for psilocybin-assisted therapy of depression.
Psilocybin for major depression granted Breakthrough Therapy by FDA
The US Food and Drug Administration (FDA) has granted psilocybin therapy a Breakthrough Therapy designation for the second time in a year, this time with a view on accelerating trials testing its efficacy treating major depressive disorder (MDD).

‘PACE-Gate’: When clinical trial evidence meets open data access
Science is not always plain sailing and sometimes the voyage is across an angry sea. A recent clinical trial of treatments for chronic fatigue syndrome (the PACE trial) has whipped up a storm of controversy. Patients claim the lead authors overstated the effectiveness of cognitive behavioural therapy and graded exercise therapy by lowering the thresholds they used to determine improvement. In this extraordinary case, patients discovered that the treatments tested had much lower efficacy after an information tribunal ordered the release of data from the PACE trial to a patient who had requested access using a freedom of information request.

Functional analytic psychotherapy
Functional analytic psychotherapy (FAP) is a psychotherapeutic approach based on clinical behavior analysis (CBA) that focuses on the therapeutic relationship as a means to maximize client change. Specifically, FAP suggests that in-session contingent responding to client target behaviors leads to significant therapeutic improvements.
UCLA discovers first stroke rehabilitation drug to repair brain damage
A new study by UCLA Health has discovered what researchers say is the first drug to fully reproduce the effects of physical stroke rehabilitation in model mice.

The Psychedelic Scientist Who Sends Brains Back to Childhood
Kids soak up new skills, adults not so much. But neuroscientist Gül Dölen might have found a way—with drugs—to help grown-ups learn like littles.

Flashback! Psychedelic research returns
Four decades after Timothy Leary, LSD shows success in medical trials. Will the right completely trip?

$250 million, 300 scientists and 40 labs: Sean Parker’s revolutionary project to ‘solve’ cancer
The collaboration, which will be formally announced Wednesday, focuses on immunotherapy -- an area of research that many believe represents the future of cancer treatment.

From treating PTSD to quitting tobacco: researchers say public investment into psychedelic drugs essential | CBC News
Magic mushrooms to treat depression, ecstasy to cure PTSD and LSD to combat alcoholism; just some of the drug-affliction pairings that have been tested in recent years.

Dopamine Nation — Anna Lembke, MD
In Dopamine Nation, Dr. Anna Lembke, psychiatrist and author, explores the exciting new scientific discoveries that explain why the relentless pursuit of pleasure leads to pain.

Ramez Naam on Twitter / X
There was a site years ago called CureTogether where patients could share information in a structured way on their disease, regimen, and progress, working towards a sort of bottoms-up clinical trial. 23andMe acquired them and it seems to be mostly dead.— Ramez Naam (@ramez) September 14, 2025